PatchSiren cyber security CVE debrief
CVE-2026-101457 Oracle Corporation CVE debrief
CVE-2026-101457 is a high-severity vulnerability in Oracle Siebel Apps - Life Sciences, specifically in the eDetailing component. The vulnerability allows a low-privileged attacker with network access via SQL to compromise Siebel Apps - Life Sciences, potentially leading to a takeover of the affected system. This vulnerability has a CVSS 3.1 Base Score of 8.8, indicating high confidentiality, integrity, and availability impacts. Defenders should assess exposure, particularly for versions 17.0 through 26.9, and apply patches or updates as soon as possible. The CVE record and Oracle advisory provide details on the vulnerability, affected versions, and potential impacts.
- Vendor
- Oracle Corporation
- Product
- Siebel Apps - Life Sciences
- CVSS
- HIGH 8.8
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-10-20
- Original CVE updated
- 2026-10-20
- Advisory published
- 2026-10-20
- Advisory updated
- 2026-10-20
Who should care
Defenders responsible for Siebel Apps - Life Sciences instances, particularly those with versions 17.0 through 26.9, should assess exposure and apply patches or updates as soon as possible.
Why it matters
CVE-2026-101457 is a high-severity vulnerability in Oracle Siebel Apps - Life Sciences that allows a low-privileged attacker to compromise the system, potentially leading to a takeover. Defenders responsible for Siebel Apps - Life Sciences instances should assess exposure and apply patches or updates as soon as possible.
- Potential takeover of Siebel Apps - Life Sciences instances
- Compromise of confidentiality, integrity, and availability
- Need for patching or updates to prevent exploitation
- Verification of network access controls and SQL interface security
Technical summary
The vulnerability in Siebel Apps - Life Sciences allows a low-privileged attacker with network access via SQL to compromise the system, potentially leading to a takeover. The CVSS 3.1 Base Score is 8.8, indicating a high severity level with significant confidentiality, integrity, and availability impacts. The vulnerability is easily exploitable and affects versions 17.0 through 26.9 of Siebel Apps - Life Sciences. Defenders should prioritize patching or updates and review network access controls and SQL interface security.
Defensive priority
High priority for defenders to assess exposure and apply patches
Recommended defensive actions
- Assess exposure of Siebel Apps - Life Sciences instances, particularly versions 17.0 through 26.9
- Apply patches or updates provided by Oracle Corporation as soon as possible
- Review network access controls and SQL interface security for Siebel Apps - Life Sciences
- Monitor for suspicious activity or potential compromises
- Verify the integrity of Siebel Apps - Life Sciences instances
- Conduct a thorough review of system configurations and security settings
- Implement additional security measures to prevent potential takeovers
Evidence notes
The CVE record and Oracle advisory provide details on the vulnerability, affected versions, and potential impacts. However, additional information on exploitation or victim organizations is not available in the supplied corpus.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-101457 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-101457
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-101457 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-101457
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
CVE-2026-101457
Unverified legacy reference
URL: https://raw.githubusercontent.com/CVEProject/cvelistV5/main/cves/2026/101xxx/CVE-2026-101457.json
cve_program_cvelist_v5
-
Source reference
Unverified legacy reference
URL: https://www.oracle.com/security-alerts/cpuoct2026.html
Supplemental source - vendor-advisory
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.